Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...

In this free webinar, learn how Pediatric Investigation Plans (PIPs) and Pediatric Study Plans (PSPs) support pediatric access and regulatory alignment. Attendees will gain insight into the practical ...

The intensified pediatric HIT2000 protocol appeared feasible and safe for the treatment of adult patients with metastatic medulloblastoma, according to study results. Perspective from James Symanowski ...

Children diagnosed with acute lymphoblastic leukemia (ALL) have significantly improved overall survival (OS) when compared with older individuals diagnosed with the disease. The improved survival in ...

An electronic sepsis alert using a combination of vital signs, risk factors and physician judgment to identify children in a pediatric emergency department with severe sepsis reduced missed diagnoses ...

Please provide your email address to receive an email when new articles are posted on . Use of a modified pediatric protocol produced favorable outcomes for adolescents and young adults with acute ...

Children with acute lymphoblastic leukemia (ALL) are treated according to risk-based protocols defined by the Children's Oncology Group (COG). Alignment between real-world clinical practice and ...

Sedation weaning protocol reduces total opioid exposure in infants following cardiac surgery In the pediatric cardiac intensive care unit (ICU), a specific sedation weaning guideline significantly ...

October 22, 2009 — A new standard protocol appears to improve survival in children with rare choroid plexus tumors, according to research presented at the 41st Annual Meeting of the International ...

The protocol, which was introduced in April, means that all children under 14 who attend at the Louth County Hospital are referred on to Our Lady of Lourdes Hospital, Drogheda.Cllr Tomas Sharkey ...

FDA accepts study protocol, providing green light for GENFIT to initiate Phase 2 clinical trial in pediatric NASH Elafibranor, the first molecule with positive results on registrational endpoint in ...